Cardinal Health, Inc. (CAH) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Cardinal Health, Inc. (CAH) Healthcare & Pipeline Overview

Cardinal Health, Inc. (CAH) is a leading integrated healthcare services and products company, providing customized solutions across the pharmaceutical and medical sectors. With a global presence and a focus on distribution and manufacturing, Cardinal Health supports hospitals, pharmacies, and patients, navigating a competitive healthcare landscape.

What Is the Investment Thesis for CAH?

Cardinal Health presents a mixed investment thesis. With a market capitalization of $54.9B and a P/E ratio of 32.46, the company's valuation reflects its established position in the healthcare distribution and manufacturing market. A key value driver is the company's diversified revenue streams from both its Pharmaceutical and Medical segments. Growth catalysts include expanding its specialty pharmaceutical services and increasing demand for its branded medical products. However, a low profit margin of 0.6% and gross margin of 3.7% indicate potential challenges in profitability. The dividend yield of 1.11% offers a modest return to investors. Monitoring the company's ability to improve margins and capitalize on growth opportunities in the healthcare sector is crucial. The beta of 0.65 suggests lower volatility compared to the market.

Based on FMP financials and quantitative analysis

CAH Key Highlights

Market Cap of $54.9B reflects its significant presence in the healthcare distribution and manufacturing sector.

• P/E Ratio of 32.46 indicates investor expectations for future earnings growth.
• Gross Margin of 3.7% highlights potential areas for improvement in operational efficiency.
• Dividend Yield of 1.11% provides a modest income stream for investors.
• Beta of 0.65 suggests lower volatility compared to the broader market, making it a potentially stable investment.

Who Are CAH's Competitors?

CAH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CAH's Key Strengths?

Diversified revenue streams across pharmaceutical and medical segments.

• Extensive distribution network and supply chain infrastructure.
• Strong relationships with pharmaceutical manufacturers and healthcare providers.
• Established brand reputation in the healthcare industry.

What Are CAH's Weaknesses?

Low profit margin compared to industry peers.

• Exposure to generic pharmaceutical pricing pressures.
• Dependence on key suppliers and manufacturers.
• Potential for supply chain disruptions.

What Could Drive CAH Stock Higher?

Expansion of specialty pharmaceutical services, driving revenue growth in a high-margin segment.

• Increased demand for Cardinal Health branded medical products, enhancing the company's market share.
• Strategic partnerships and acquisitions, expanding the company's capabilities and geographic reach.
• Enhancement of supply chain solutions, improving efficiency and customer satisfaction.

What Are the Key Risks for CAH?

Negative return on equity (-55.7%) — the business is not currently generating profit on shareholder capital.

• Rich valuation — a P/E of 32.46 runs well above the Healthcare sector’s ~21.50x, leaving little room for a miss.
• Insider selling — insiders were net sellers of roughly $113.1M recently.
• Increased competition from other distributors and manufacturers, potentially impacting market share.
• Regulatory changes and healthcare reform, creating uncertainty and potential cost pressures.
• Economic downturns and reduced healthcare spending, affecting revenue and profitability.
• Product liability claims and recalls, leading to financial losses and reputational damage.
• Generic pharmaceutical pricing pressures, impacting the profitability of the Pharmaceutical segment.

What Are the Growth Opportunities for CAH?

• Expansion of Specialty Pharmaceutical Services: Cardinal Health can capitalize on the growing demand for specialty pharmaceutical products and services. By expanding its offerings in this area, including distribution, patient support, and pharmacy management, the company can increase its revenue and market share. The specialty pharmaceutical market is projected to reach $500 billion by 2028, presenting a significant growth opportunity for Cardinal Health. Timeline: Ongoing.
• Increased Demand for Branded Medical Products: The company's Medical segment can benefit from the increasing demand for Cardinal Health branded medical, surgical, and laboratory products. By focusing on innovation and quality, Cardinal Health can strengthen its brand and expand its customer base. The global medical device market is expected to reach $600 billion by 2027, offering substantial growth potential. Timeline: Ongoing.
• Strategic Partnerships and Acquisitions: Cardinal Health can pursue strategic partnerships and acquisitions to expand its capabilities and geographic reach. By partnering with or acquiring companies that offer complementary products or services, Cardinal Health can enhance its value proposition and strengthen its competitive position. This includes potential acquisitions in the supply chain management and healthcare technology sectors. Timeline: Ongoing.
• Enhancement of Supply Chain Solutions: Cardinal Health can further develop its supply chain services and solutions to meet the evolving needs of hospitals, ambulatory surgery centers, and other healthcare providers. By leveraging technology and data analytics, Cardinal Health can improve efficiency, reduce costs, and enhance customer satisfaction. Timeline: Ongoing.
• Geographic Expansion: Cardinal Health has opportunities to expand its presence in international markets, particularly in Asia and Europe. By entering new markets or expanding its existing operations, Cardinal Health can diversify its revenue streams and reduce its reliance on the U.S. market. The global healthcare market is experiencing rapid growth in emerging economies, presenting significant opportunities for Cardinal Health. Timeline: Ongoing.

What Are CAH's Competitive Advantages?

• Scale: Cardinal Health's large scale provides it with significant purchasing power and distribution efficiencies.
• Established Relationships: Long-standing relationships with pharmaceutical manufacturers and healthcare providers create a strong competitive advantage.
• Integrated Services: The company's integrated services, including pharmaceutical distribution, medical product manufacturing, and supply chain solutions, offer a comprehensive value proposition.
• Brand Recognition: The Cardinal Health brand is well-recognized and respected in the healthcare industry.

What Does CAH Do?

Cardinal Health, Inc., incorporated in 1979 and headquartered in Dublin, Ohio, operates as an integrated healthcare services and products company across the United States, Canada, Europe, Asia, and internationally. The company provides customized solutions to a diverse range of healthcare providers, including hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. Cardinal Health operates through two primary segments: Pharmaceutical and Medical. The Pharmaceutical segment focuses on the distribution of branded and generic pharmaceuticals, specialty pharmaceutical products, and over-the-counter healthcare and consumer products. This segment also offers services to pharmaceutical manufacturers and healthcare providers, including the operation of nuclear pharmacies and radiopharmaceutical manufacturing facilities. Additionally, it repackages generic pharmaceuticals and over-the-counter products and provides medication therapy management and pharmacy management services. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices. These products include exam and surgical gloves, needles, syringes, sharps disposals, compressions, incontinence products, nutritional delivery products, wound care products, surgical drapes, gowns, fluid suction systems, urology products, operating room supplies, and electrode product lines. The segment also distributes national brand products and provides supply chain services to healthcare providers. Cardinal Health plays a crucial role in the healthcare supply chain, ensuring the efficient delivery of essential products and services.

What Products and Services Does CAH Offer?

• Distributes branded and generic pharmaceutical products.
• Provides services to pharmaceutical manufacturers and healthcare providers.
• Operates nuclear pharmacies and radiopharmaceutical manufacturing facilities.
• Repackages generic pharmaceuticals and over-the-counter healthcare products.
• Manufactures and distributes Cardinal Health branded medical, surgical, and laboratory products.
• Provides supply chain services and solutions to hospitals and other healthcare providers.
• Assembles and sells sterile and non-sterile procedure kits.

How Does CAH Make Money?

• Generates revenue through the distribution of pharmaceutical products to pharmacies, hospitals, and other healthcare providers.
• Earns revenue from the sale of Cardinal Health branded medical products and devices.
• Provides supply chain and logistics services to healthcare organizations.
• Offers specialized services such as nuclear pharmacy operations and medication therapy management.

What Industry Does CAH Operate In?

Cardinal Health operates within the medical distribution industry, which is characterized by increasing demand for efficient supply chain solutions and a growing need for pharmaceutical and medical products. The industry is influenced by factors such as aging populations, advancements in medical technology, and regulatory changes. Cardinal Health competes with companies like Cencora, Inc. and Becton, Dickinson and Company, focusing on providing comprehensive healthcare solutions to hospitals, pharmacies, and other healthcare providers. The global healthcare market is expected to continue growing, driven by increased healthcare spending and the rising prevalence of chronic diseases.

Who Are CAH's Key Customers?

• Hospitals and healthcare systems.
• Pharmacies (retail and institutional).
• Ambulatory surgery centers.
• Clinical laboratories.
• Physician offices.

Company Profile

Cardinal Health, Inc. operates in the Medical - Distribution industry within the Healthcare sector. It is headquartered in Dublin, US. The company is led by CEO Jason Hollar. CAH has traded publicly since 1983.

Cardinal Health, Inc. Financial Trajectory

Cardinal Health, Inc. (CAH) reported $63.86B in revenue for Q4 FY2026, reflecting 4.8% growth compared to the prior quarter. The company recorded net income of $394.0M, with diluted EPS of $1.66. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Healthcare. Across the four most recent quarters, CAH averaged $1.81 in diluted EPS.

How Cardinal Health, Inc. Is Valued

Cardinal Health, Inc. carries a market capitalization of $54.9B, placing it in the large-cap category. Analyst price targets span from $250.00 to $292.00, with a consensus of $273.22. At the current price of $234.29, that implies approximately 17% upside potential. Relative to its peer group, CAH's quantitative score of 87/100 is roughly in line with the peer average of 82/100.

Return on equity for Cardinal Health, Inc. stands at -55.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.8%, showing how much profit it generates from its asset base. CAH trades at a trailing price-to-earnings ratio of 32.46, above the Healthcare sector average of ~21.50x. Its free cash flow yield is 8.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.91 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 3.1%, the inverse of the P/E and a quick read on earnings relative to price.

Cardinal Health, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 5.09 places it in the safe zone, indicating low near-term bankruptcy risk.

Cardinal Health, Inc. has beaten Wall Street's EPS estimate in 8 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 12.6% above estimates on average.

Over the past six months, Cardinal Health, Inc. insiders filed 56 SEC Form 4 transactions — 39 sales and 17 purchases. On net that is roughly 2K shares acquired (about $113.1M) — insiders putting money in tends to read as conviction.

CAH Financials

Next earnings report: Oct 29, 2026

CAH Latest News

CAH Analyst Consensus

CAH MoonshotScore

Latest Cardinal Health, Inc. Analysis

Common Questions About CAH (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources